Navigation Links
A ray of hope in treating blindness and other eye disorders

A recent study has focused on the communication processes between cells that could perhaps be extrapolated to prevent the spread of damaged cells, leading to blindness.

Normally cells have a blood supply to send nutrients from // one cell to the other, enabling communication. For cells that don't have that, there has to be tiny bridge like connections, which enables movement of molecules to and fro in the same way. This type of a communication network is found in cells of the eye.

What is beneficial in one way may be harmful in another way. For example, if a cell is damaged, then the damage is communicated to the neighboring cell also, thereby damaging it. The damage continues to spread, leading to severe eye damage if the gap junctions are not closed off.

If some mechanism is invented to close this channel between the cells, the damage can be restricted to the parent cell and protecting the rest. Research is currently being done to develop a chemical that would stop the spread of damaged cells. The main concern for scientists in the process of injecting the chemical into the eye is to do so without damaging the retina.

The blood brain barrier, which restricts the certain drugs or other substances from reaching the brain and eye, poses serious technical difficulties. If this difficulty were overcome, the treating eye disorder would be made all the more simple.
'"/>




Page: 1

Related medicine news :

1. Gene Therapy shows promise in treating Hemophilia
2. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
3. Diuretics are better for treating blood pressure problems than newer medicines
4. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
5. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
6. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
7. Lower doses of oral contraceptives helpful in treating acne
8. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
9. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
10. Antidepressant drugs best for treating Depression
11. Thalidomide is the new approved drug for treating multiple cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: